Cargando…
DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer
Chemotherapies based on platinum have been the standard first-line treatment for patients with small-cell lung cancer(SCLC) in the past years. However, the progression of patients occurs mostly due to rapid development of resistance to chemotherapy. In addition, the mechanisms involved in developmen...
Autores principales: | Li, Man, Lin, Anqi, Luo, Peng, Shen, Weitao, Xiao, Dan, Gou, Lanying, Zhang, Jian, Guo, Linlang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053592/ https://www.ncbi.nlm.nih.gov/pubmed/31959735 http://dx.doi.org/10.18632/aging.102683 |
Ejemplares similares
-
Novel homozygous mutations of DNAH5 in Kartagener syndrome
por: Cheng, Xian-Dong, et al.
Publicado: (2021) -
Co-occurrence of Moyamoya syndrome and Kartagener syndrome caused by the mutation of DNAH5 and DNAH11: a case report
por: Zhang, Lili, et al.
Publicado: (2020) -
A novel frameshift mutation in DNAH6 associated with male infertility and asthenoteratozoospermia
por: Huang, Fei, et al.
Publicado: (2023) -
A Japanese Case of Primary Ciliary Dyskinesia with DNAH5 Mutations
por: Orimo, Mami, et al.
Publicado: (2019) -
DNAH7 mutations benefit colorectal cancer patients receiving immune checkpoint inhibitors
por: Yang, Wenjuan, et al.
Publicado: (2022)